Joost de Bruijn
Fondateur chez KUROS BIOSCIENCES AG
Fortune : 19 M $ au 30/06/2024
Profil
Joost D.
de Bruijn is the founder of Xpand Biotechnology BV (founded in 2005) and Progentix Orthobiology BV (founded in 2007).
He is also the founder of Scinus Cell Expansion BV.
Currently, Dr. de Bruijn holds the position of Executive Director & President-Innovation at Kuros Biosciences Ltd.
(founded in 2017).
He is currently a Professor at the University of London (since 2014) and Queen Mary University of London (since 2004).
Previously, he worked as a Research Director at IsoTis SA and as a Professor at the University of Twente (2011-2019).
Dr. de Bruijn obtained his doctorate degree from the University of Leiden in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KUROS BIOSCIENCES LTD.
3,94% | 31/12/2022 | 1 462 455 ( 3,94% ) | 19 M $ | 30/06/2024 |
Postes actifs de Joost de Bruijn
| Sociétés | Poste | Début |
|---|---|---|
| KUROS BIOSCIENCES AG | Fondateur | - |
| University of London | Corporate Officer/Principal | 18/03/2014 |
| Queen Mary University of London | Corporate Officer/Principal | 01/01/2004 |
Anciens postes connus de Joost de Bruijn
| Sociétés | Poste | Fin |
|---|---|---|
| University of Twente | Corporate Officer/Principal | 01/01/2019 |
| Scinus Cell Expansion BV | Fondateur | - |
IsoTis SA
 IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Directeur Technique/Scientifique/R&D | - |
Xpand Biotechnology BV
 Xpand Biotechnology BV BiotechnologyHealth Technology Xpand Biotechnology BV develops innovative technologies in the area of cell cultivation and regenerative medicine. Its bioreactor system enables clinical scale cell cultivation in a controlled environment and provides a cost effective alternative to 2 dimensional cell growth in tissue culture flasks or cell stacks. The company was founded by Joost D. de Bruijin and Frank-Jan van der Velden in 2004 and is headquartered in Bilthoven, the Netherlands. | Directeur Général | - |
Progentix Orthobiology BV
 Progentix Orthobiology BV Medical SpecialtiesHealth Technology Progentix Orthobiology BV develops CuriOs (TM), a unique suite of osteoconductive material products for clinical application in bone regenerative surgery. The company was founded by Joost Dick de Bruijn and Clemens A. van Blitterswijk in 2007 and is headquartered in Bilthoven, the Netherlands. | Directeur Général | - |
Formation de Joost de Bruijn
| University of Leiden | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KUROS BIOSCIENCES AG | Health Technology |
| Entreprise privées | 4 |
|---|---|
Progentix Orthobiology BV
Progentix Orthobiology BV Medical SpecialtiesHealth Technology Progentix Orthobiology BV develops CuriOs (TM), a unique suite of osteoconductive material products for clinical application in bone regenerative surgery. The company was founded by Joost Dick de Bruijn and Clemens A. van Blitterswijk in 2007 and is headquartered in Bilthoven, the Netherlands. | Health Technology |
IsoTis SA
IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Health Technology |
Xpand Biotechnology BV
Xpand Biotechnology BV BiotechnologyHealth Technology Xpand Biotechnology BV develops innovative technologies in the area of cell cultivation and regenerative medicine. Its bioreactor system enables clinical scale cell cultivation in a controlled environment and provides a cost effective alternative to 2 dimensional cell growth in tissue culture flasks or cell stacks. The company was founded by Joost D. de Bruijin and Frank-Jan van der Velden in 2004 and is headquartered in Bilthoven, the Netherlands. | Health Technology |
| Scinus Cell Expansion BV |
